ARCHIVES

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

This article is from The Cancer Letter archive.

Vol. 08 No. 06 | February 5, 1982

Download PDF Visit The Full Archive

Related Articles

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Anamorelin Increases Body Mass In Two Global Phase III Trials

October 31, 2014

Funding Opportunities.

July 19, 2002

NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group

March 21, 1997

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

Bush Nominates von Eschenbach For FDA; Democrats Put Hold On Confirmation. von Eschenbach To Step Down As NCI Director, But Details Unavailable; No Acting Director Named. Applause, Outrage, Over Nomination. Now, von Eschenbach Leads A Retreat From 2015 Target Date For His Challenge Goal.

March 17, 2006